ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983

Zinder Report Implementation, Surgical Conference, On NCAB Meeting June 17-18

May 31, 1974

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

NCAB Action On Diet FIT “Not Cavalier,” Chairman Korn Says

November 10, 1989

November issue of Business & Regulatory Report included.

November 28, 2003

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010